Your session is about to expire
← Back to Search
Stimulant vs Non-stimulant Treatments for ADHD (MPH-ATX Trial)
MPH-ATX Trial Summary
This trial will study how well ADHD medications work in kids with ADHD who also have ODD or CD. They will use fMRI to look at the reward systems in their brains.
MPH-ATX Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMPH-ATX Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MPH-ATX Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have metal in your body that cannot be taken out, like braces or a metal plate.I have not taken stimulant medications recently, but non-stimulants are okay.I don't have conditions like severe fear of enclosed spaces or extreme obesity that prevent me from undergoing scans.You were exposed to alcohol or drugs before you were born.I am in the early stages of puberty.I am between 7 and 12 years old.I do not have any major neurological or medical illnesses.You have thoughts of hurting yourself or have tried to harm yourself in the past.You have a severe behavioral disorder called Conduct Disorder (CD) or Oppositional Defiant Disorder (ODD). You also have at least two symptoms of CD as determined by a specific assessment tool called C-DISC.You have started puberty too early or you are currently pregnant.I have been diagnosed with a major psychiatric disorder.I can communicate in English well enough to understand and sign consent forms.You have had a previous injury to your head.I have vision problems that could affect my ability to perform tasks.
- Group 1: Methylphenidate
- Group 2: Atomoxetine
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does Atomoxetine present any adverse risks to users?
"Atomoxetine has been approved for use after thorough testing, so it is given a rating of 3 on our safety scale."
Is the age bracket for this experiment limited to adults or is it open to all ages?
"The age range for enrolment into this clinical trial is between 7 and 12. Furthermore, there are 120 slots available to those below 18 years of age, as well as 53 spots open to adults over 65."
Is enrollment still open for participation in this experiment?
"To qualify for this trial, applicants must have a diagnosis of ADHD and be aged between 7 and 12. Accommodating 44 children in total, this study is now open for enrolment."
What is the participation level of this trial?
"Affirmative. Clinicaltrials.gov's records show that this experiment, which was initially advertised on June 4th 2019, is presently signing up patients. The trial requires 44 people to come from 1 specific site in order to be successful."
Could you elaborate on previous experiments utilizing Atomoxetine?
"Currently, 39 Atomoxetine studies are ongoing with 4 of them being in Phase 3. While the majority of these investigations originate from Houston, Texas, a wide network spanning 126 sites is working to advance this medication's development."
Are there any open opportunities for participants to join this clinical trial?
"Clinical trials.gov states that this research endeavour is currently recruiting participants, having first been posted on June 4th 2019 and updated April 5th 2022."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger